FDA-TRACK: Other FDA Programs
Subscribe now!
Interested in receiving FDA-TRACK updates in your inbox?
FDA's Other Programs include several offices that provide centralized agency-wide program direction and management services. It also includes several offices that support FDA's consumer protection efforts and function along-side FDA's Centers.
Each FDA-TRACK program area collects, analyzes, and reports its performance measures and results. Explore the progress Other FDA Programs are making by following the links to the offices below:
Office of the Executive Secretariat
FDA's Office of the Executive Secretariat (OES or “Exec Sec”) integrates critical Agency administrative and communication functions to ensure high-quality information is shared.
Office of External Affairs
FDA's Office of External Affairs (OEA) serves as the central point of communication and education about the FDA’s public health and regulatory activity.
Office of Global Policy and Strategy
FDA's Office of Global Policy and Strategy is the focal point for all international matters concerning the Agency.
Office of Operations
FDA's Office of Operations (OO) provides leadership for operational activities, interaction and execution of program initiatives across the Office of the Commissioner (OC) and FDA centers, field offices and regions.
Office of Minority Health and Health Equity
FDA’s Office of Minority Health and Health Equity (OMHHE) works to promote and protect the health of diverse populations through research and communication of science that addresses health disparities.
Office of Clinical Policy and Programs
FDA's Office of Clinical Policy and Programs includes Office of Combination Products (OCP), Office of Orphan Products Development (OOPD), and Office of Pediatric Therapeutics (OPT).
Office of Women's Health
FDA's Office of Women's Health(OWH) supports FDA’s regulatory mission by engaging in scientific research and collaborating with stakeholders to engage in scientific and educational projects.
FDASIA-TRACK
FDA will communicate its progress towards accomplishing the requirements of the FDA Safety and Innovation Act (FDASIA).
Completed Measures and Key Projects
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time.